Category Archives: Medical Devices

Below, we are re-publishing with permission the press-release issued by Sequana Medical on November 15, 2022 15 November 2022, 07:00 am CET Ghent, Belgium – 15 November 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of … Continue reading →

Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on October 20, 2022 Spatial Resynchronization Therapy (SR™T) demonstrates proof-of-concept in repeatedly terminating atrial fibrillation (AFib) and restoring sinus rhythm SAN DIEGO, CALIFORNIA, UNITED STATES, October 20, 2022 … Continue reading →

Below, we are re-publishing with permission the press-release issued by Axon Therapies on May 26, 2022 Late-breaking results presented at the European Society of Cardiology’s Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart … Continue reading →

Below, we are re-publishing with permission the press-release issued by AtriAN Medical on September 06, 2022 This follow-up trial builds on AtriAN’s initial safety and feasibility study and aims to assess the efficacy of its cardioneuroablation treatment in patients with atrial … Continue reading →

Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems, Inc. on March 16, 2022 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with … Continue reading →

Spatial Resynchronization Therapy™ (SR ™Т) Successfully Terminated Atrial Fibrillation Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on July 14, 2022 SAN DIEGO, Calif., July 14, 2022. Maxwell Biomedical announced today that it has initiated its … Continue reading →

Clinical Accelerator, a full-service, medical device focused contract research organization, is excited to announce a new collaboration with Argá Medtech, on their feasibility study exploring the safety and efficacy of Argá’s non-thermal cardiac ablation system targeting Atrial Fibrillation (AF) The … Continue reading →

Below, we are re-publishing with permission the press-release issued by Miracor Medical on March 29, 2022 AWANS, Belgium, March 29, 2022 /PRNewswire/ — Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits … Continue reading →